nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acquired CD38 gene deletion as a mechanism of tumor antigen escape in multiple myeloma
|
Portuguese, Andrew J. |
|
|
7 |
23 |
p. 7235-7238 |
artikel |
2 |
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease
|
Hankins, Jane S. |
|
|
7 |
23 |
p. 7190-7201 |
artikel |
3 |
Another step toward frontline BTK inhibitor therapy in MCL
|
Hanel, Walter |
|
|
7 |
23 |
p. 7358-7360 |
artikel |
4 |
Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization
|
Teierle, Samantha M. |
|
|
7 |
23 |
p. 7239-7242 |
artikel |
5 |
COVID-19 in patients with classic and variant hairy cell leukemia
|
Kreitman, Robert J. |
|
|
7 |
23 |
p. 7161-7168 |
artikel |
6 |
Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL
|
O’Connor, David |
|
|
7 |
23 |
p. 7231-7234 |
artikel |
7 |
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
|
Spasevska, Ivana |
|
|
7 |
23 |
p. 7216-7230 |
artikel |
8 |
Early response markers predict survival after etoposide-based therapy of hemophagocytic lymphohistiocytosis
|
Verkamp, Bethany |
|
|
7 |
23 |
p. 7258-7269 |
artikel |
9 |
E-cadherin/β-catenin expression is conserved in human and rat erythropoiesis and marks stress erythropoiesis
|
Krimpenfort, Rosa A. |
|
|
7 |
23 |
p. 7169-7183 |
artikel |
10 |
Editorial Board
|
|
|
|
7 |
23 |
p. i |
artikel |
11 |
Evaluating the prevalence of inborn errors of immunity in adults with chronic immune thrombocytopenia or Evans syndrome
|
Jiang, Debbie |
|
|
7 |
23 |
p. 7202-7208 |
artikel |
12 |
Front Matter
|
|
|
|
7 |
23 |
p. ii |
artikel |
13 |
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma
|
Camus, Vincent |
|
|
7 |
23 |
p. 7331-7345 |
artikel |
14 |
Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type
|
Emile, Jean-François |
|
|
7 |
23 |
p. 7254-7257 |
artikel |
15 |
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma
|
Karmali, Reem |
|
|
7 |
23 |
p. 7361-7368 |
artikel |
16 |
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
|
Syrykh, Charlotte |
|
|
7 |
23 |
p. 7384-7391 |
artikel |
17 |
JAK2V617F and ischemic stroke: CHIP or CMD-NBV?
|
Barosi, Giovanni |
|
|
7 |
23 |
p. 7329-7330 |
artikel |
18 |
Loss of early myeloid donor cell engraftment into the central nervous system with nonmyeloablative conditioning
|
Nolan, Erin E. |
|
|
7 |
23 |
p. 7290-7294 |
artikel |
19 |
Loss of GSK3β in hematopoietic stem cells results in normal hematopoiesis in mice
|
Lee, Grace |
|
|
7 |
23 |
p. 7185-7189 |
artikel |
20 |
Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A
|
Agosti, Pasquale |
|
|
7 |
23 |
p. 7209-7215 |
artikel |
21 |
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms
|
Durham, Benjamin H. |
|
|
7 |
23 |
p. 7319-7328 |
artikel |
22 |
Neurocognitive impairment associated with chronic morbidity in long-term survivors of Hodgkin Lymphoma
|
Phillips, Nicholas S. |
|
|
7 |
23 |
p. 7270-7278 |
artikel |
23 |
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
|
Desai, Sanjal H. |
|
|
7 |
23 |
p. 7295-7303 |
artikel |
24 |
Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant
|
Lin, Andrew |
|
|
7 |
23 |
p. 7153-7160 |
artikel |
25 |
Pirillo C, Birch F, Tissot FS, et al. Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness. Blood Adv. 2022;6(10):3126-3141.
|
|
|
|
7 |
23 |
p. 7184 |
artikel |
26 |
Preferences for potential benefits and risks for gene therapy in the treatment of sickle cell disease
|
Gonzalez Sepulveda, Juan Marcos |
|
|
7 |
23 |
p. 7371-7381 |
artikel |
27 |
Runx1-R188Q germ line mutation induces inflammation and predisposition to hematologic malignancies in mice
|
Ahmad, Mohd Hafiz |
|
|
7 |
23 |
p. 7304-7318 |
artikel |
28 |
The challenge of eliciting opinions of gene therapy for SCD
|
Limerick, Emily M. |
|
|
7 |
23 |
p. 7369-7370 |
artikel |
29 |
The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing
|
Maierhofer, Anna |
|
|
7 |
23 |
p. 7346-7357 |
artikel |
30 |
The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study
|
Hijiya, Nobuko |
|
|
7 |
23 |
p. 7279-7289 |
artikel |
31 |
Time to include IGLV3-21R110 status in CLL prognostication?
|
Rosenquist, Richard |
|
|
7 |
23 |
p. 7382-7383 |
artikel |
32 |
TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era
|
Landsburg, Daniel J. |
|
|
7 |
23 |
p. 7243-7253 |
artikel |